EP 1007019 A2 20000614 - CHOLESTEROL-LOWERING THERAPY
Title (en)
CHOLESTEROL-LOWERING THERAPY
Title (de)
CHOLESTEROLVERRINGERNDE THERAPIE
Title (fr)
THERAPIE HYPOCHOLESTEROLEMIANTE
Publication
Application
Priority
- GB 9814415 A 19980703
- GB 9815851 A 19980721
- US 9817459 W 19980821
- US 5696697 P 19970826
- US 7685998 P 19980305
- US 8536098 P 19980513
Abstract (en)
[origin: WO9909967A2] Methods are described for preventing or reducing the risk of a first occurrence of a cardiovascular event using an HMG-CoA reductase inhibitor alone or in combination with another lipid altering agent. Subjects to be treated are those having an average serum total cholesterol level, an average to mildly elevated serum low-density lipoprotein cholesterol level, and a below average serum high-density lipoprotein cholesterol level, with no history of clinically evident coronary disease.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/351 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/351 (2013.01); A61K 45/06 (2013.01)
Citation (search report)
See references of WO 9909967A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9909967 A2 19990304; WO 9909967 A3 19990520; WO 9909967 B1 19990708; AU 9115398 A 19990316; CA 2300165 A1 19990304; EP 1007019 A2 20000614
DOCDB simple family (application)
US 9817459 W 19980821; AU 9115398 A 19980821; CA 2300165 A 19980821; EP 98943329 A 19980821